Annual EBITDA:
-$336.07M-$114.56M(-51.72%)Summary
- As of today, CRNX annual EBITDA is -$336.07 million, with the most recent change of -$114.56 million (-51.72%) on December 31, 2024.
- During the last 3 years, CRNX annual EBITDA has fallen by -$229.29 million (-214.73%).
- CRNX annual EBITDA is now -5580.68% below its all-time high of -$5.92 million, reached on December 31, 2016.
Performance
CRNX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$128.15M-$17.67M(-16.00%)Summary
- As of today, CRNX quarterly EBITDA is -$128.15 million, with the most recent change of -$17.67 million (-16.00%) on June 30, 2025.
- Over the past year, CRNX quarterly EBITDA has dropped by -$46.12 million (-56.23%).
- CRNX quarterly EBITDA is now -5348.68% below its all-time high of -$2.35 million, reached on September 30, 2017.
Performance
CRNX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$419.62M-$46.12M(-12.35%)Summary
- As of today, CRNX TTM EBITDA is -$419.62 million, with the most recent change of -$46.12 million (-12.35%) on June 30, 2025.
- Over the past year, CRNX TTM EBITDA has dropped by -$143.43 million (-51.93%).
- CRNX TTM EBITDA is now -16183.16% below its all-time high of -$2.58 million, reached on March 31, 2017.
Performance
CRNX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRNX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -51.7% | -56.2% | -51.9% |
| 3Y3 Years | -214.7% | -199.2% | -211.7% |
| 5Y5 Years | -534.8% | -668.1% | -522.4% |
CRNX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -214.7% | at low | -196.6% | at low | -179.2% | at low |
| 5Y | 5-Year | -534.8% | at low | -603.9% | at low | -522.4% | at low |
| All-Time | All-Time | -5580.7% | at low | -5348.7% | at low | >-9999.0% | at low |
CRNX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$128.15M(-16.0%) | -$419.62M(-12.3%) |
| Mar 2025 | - | -$110.48M(-17.6%) | -$373.49M(-11.1%) |
| Dec 2024 | -$336.07M(-51.7%) | -$93.96M(-8.0%) | -$336.07M(-10.4%) |
| Sep 2024 | - | -$87.03M(-6.1%) | -$304.51M(-10.3%) |
| Jun 2024 | - | -$82.03M(-12.3%) | -$276.19M(-11.9%) |
| Mar 2024 | - | -$73.06M(-17.1%) | -$246.87M(-11.4%) |
| Dec 2023 | -$221.51M(-32.7%) | -$62.40M(-6.3%) | -$221.51M(-7.3%) |
| Sep 2023 | - | -$58.70M(-11.4%) | -$206.39M(-8.1%) |
| Jun 2023 | - | -$52.72M(-10.5%) | -$190.89M(-5.5%) |
| Mar 2023 | - | -$47.70M(-0.9%) | -$181.01M(-8.5%) |
| Dec 2022 | -$166.90M(-56.3%) | -$47.28M(-9.4%) | -$166.90M(-11.1%) |
| Sep 2022 | - | -$43.21M(-0.9%) | -$150.28M(-11.6%) |
| Jun 2022 | - | -$42.83M(-27.5%) | -$134.64M(-14.4%) |
| Mar 2022 | - | -$33.59M(-9.6%) | -$117.67M(-10.2%) |
| Dec 2021 | -$106.78M | -$30.65M(-11.2%) | -$106.78M(-9.3%) |
| Sep 2021 | - | -$27.57M(-6.6%) | -$97.69M(-10.6%) |
| Jun 2021 | - | -$25.86M(-13.9%) | -$88.33M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$22.69M(-5.2%) | -$79.15M(-7.0%) |
| Dec 2020 | -$74.00M(-39.8%) | -$21.57M(-18.4%) | -$74.00M(-9.8%) |
| Sep 2020 | - | -$18.21M(-9.1%) | -$67.42M(-5.0%) |
| Jun 2020 | - | -$16.68M(+4.9%) | -$64.22M(-5.9%) |
| Mar 2020 | - | -$17.55M(-17.1%) | -$60.65M(-14.5%) |
| Dec 2019 | -$52.95M(-87.5%) | -$14.98M(+0.1%) | -$52.95M(-12.2%) |
| Sep 2019 | - | -$15.00M(-14.4%) | -$47.18M(-17.6%) |
| Jun 2019 | - | -$13.12M(-33.2%) | -$40.11M(-23.0%) |
| Mar 2019 | - | -$9.84M(-6.7%) | -$32.60M(-15.5%) |
| Dec 2018 | -$28.24M(-213.8%) | -$9.22M(-16.3%) | -$28.24M(-31.6%) |
| Sep 2018 | - | -$7.93M(-41.4%) | -$21.47M(-35.1%) |
| Jun 2018 | - | -$5.61M(-2.4%) | -$15.89M(-54.5%) |
| Mar 2018 | - | -$5.48M(-123.6%) | -$10.28M(-39.3%) |
| Dec 2017 | -$9.00M(-52.1%) | -$2.45M(-4.2%) | -$7.38M(-49.7%) |
| Sep 2017 | - | -$2.35M(+8.7%) | -$4.93M(-91.3%) |
| Mar 2017 | - | -$2.58M | -$2.58M |
| Dec 2016 | -$5.92M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of CRNX is -$336.07M
What is the all-time high annual EBITDA for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual EBITDA is -$5.92M
What is Crinetics Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, CRNX annual EBITDA has changed by -$114.56M (-51.72%)
What is Crinetics Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of CRNX is -$128.15M
What is the all-time high quarterly EBITDA for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$2.35M
What is Crinetics Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, CRNX quarterly EBITDA has changed by -$46.12M (-56.23%)
What is Crinetics Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of CRNX is -$419.62M
What is the all-time high TTM EBITDA for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM EBITDA is -$2.58M
What is Crinetics Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, CRNX TTM EBITDA has changed by -$143.43M (-51.93%)